EP 1007063 A1 20000614 - BONE REGENERATION IN OSTEOPOROSIS USING HUMAN BONE MARROW MESENCHYMAL CELLS
Title (en)
BONE REGENERATION IN OSTEOPOROSIS USING HUMAN BONE MARROW MESENCHYMAL CELLS
Title (de)
KNOCHENREGENERATION BEI OSTEOPOROSE UNTER VERWENDUNG VON MESENCHYMZELLEN VON MENSCHLICHEM KNOCHENMARK
Title (fr)
REGENERATION OSSEUSE DANS LE CADRE DE L'OSTEOPOROSE A L'AIDE DE CELLULES MESENCHYMATEUSES DE MOELLE OSSEUSE HUMAINE
Publication
Application
Priority
- US 9801112 W 19980122
- US 3638897 P 19970124
Abstract (en)
[origin: WO9832450A1] The method of osteoporosis treatment and infusion compositions of the invention increase the number of the patient's own progenitor cells (hMSCs) and the reservoir of available bone-forming osteoblasts. They can be used to generate cortical and cancellous bone which has been lost as a result of post-menopausal osteoporosis, male idiopathic osteoporosis, congenital osteoporosis and other bone resorption diseases. Most cases of osteoporosis can be treated with a metered intravenous infusion of the composition of the invention over the course of 15-30 minutes, using customary cell reinfusion therapy techniques.
IPC 1-7
IPC 8 full level
A61K 35/28 (2006.01); A61P 19/10 (2006.01); A61P 43/00 (2006.01); C12N 5/06 (2006.01); C12N 5/0775 (2010.01); C12N 5/08 (2006.01); A61K 35/12 (2006.01)
CPC (source: EP)
A61P 19/10 (2017.12); A61P 43/00 (2017.12); C12N 5/0663 (2013.01); A61K 2035/124 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9832450 A1 19980730; AU 6033898 A 19980818; CA 2278539 A1 19980730; EP 1007063 A1 20000614; EP 1007063 A4 20020424; EP 2179738 A2 20100428; EP 2179738 A3 20100505; JP 2001509163 A 20010710
DOCDB simple family (application)
US 9801112 W 19980122; AU 6033898 A 19980122; CA 2278539 A 19980122; EP 10000798 A 19980122; EP 98903613 A 19980122; JP 53210398 A 19980122